"Hyperprolactinemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Descriptor ID |
D006966
|
| MeSH Number(s) |
C10.228.140.617.738.250.450 C19.700.355.600
|
| Concept/Terms |
Hyperprolactinemia- Hyperprolactinemia
- Hyperprolactinemias
- Prolactin, Inappropriate Secretion
- Inappropriate Secretion Prolactin
- Secretion Prolactin, Inappropriate
- Inappropriate Prolactin Secretion Syndrome
- Prolactin Hypersecretion Syndrome
- Hypersecretion Syndrome, Prolactin
- Syndrome, Prolactin Hypersecretion
- Hyperprolactinaemia
- Inappropriate Prolactin Secretion
- Prolactin Secretion, Inappropriate
- Secretion, Inappropriate Prolactin
|
Below are MeSH descriptors whose meaning is more general than "Hyperprolactinemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperprolactinemia".
This graph shows the total number of publications written about "Hyperprolactinemia" by people in this website by year, and whether "Hyperprolactinemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 2 | 1 | 3 |
| 2019 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyperprolactinemia" by people in Profiles.
-
Metabolic syndrome in the era of COVID-19 outbreak: impact of lockdown on cardiometabolic health. J Endocrinol Invest. 2021 Dec; 44(12):2845-2847.
-
Prevalence and Course of Endocrinopathy in POEMS Syndrome. J Clin Endocrinol Metab. 2019 06 01; 104(6):2140-2146.
-
Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding? Clin Rheumatol. 2019 May; 38(5):1263-1270.
-
The value of prolactin in predicting prolactin?ma in hyperprolactinaemic polycystic ovarian syndrome. Eur J Clin Invest. 2018 Jul; 48(7):e12961.
-
Prolactin and Autoimmunity. Front Immunol. 2018; 9:73.
-
The effects of hyperprolactinemia and its control on metabolic diseases. Expert Rev Endocrinol Metab. 2018 03; 13(2):99-106.
-
Hyperprolactinemia and the Association with All-Cause Mortality and Cardiovascular Mortality. Horm Metab Res. 2017 Jun; 49(6):411-417.
-
Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials. J Psychopharmacol. 2017 05; 31(5):625-631.
-
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics. Front Neuroendocrinol. 2017 04; 45:25-34.
-
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia. J Clin Psychiatry. 2016 Dec; 77(12):e1557-e1563.